Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opty

You seem to want to engage in battles with me and others for the sake of arguing and little else. These are merely distractions from the real talking points. Help me out here...so that I can better understand where you are coming from. I would like to know:

1. Did you vote for majority voting last year and if so, what do you think of the BoD's move to circumvent the will of the shareholders?

2. Regarding the frequently asked question about why there has been no increase in licensing activity since the settlement....What do you honestly think of the "weak at best" answer that refers back to standard risk language in every financial statement?

3. When asked how Patriot could abandon the serious claims levied against TPL by PTSC, the company responded that they believed the achievments afforded by the settlement were in the best interest of the licensing program and therefore Patriot's shareholders. I will remind you that in the first amended complaint Patriot asked

For a declaration of Patriot’s right to declare the ComAg terminated

To me, this was a clear message that PTSC wanted no continued interest in the licensing program with TPL and yet....suddenly it is once again in the best interest of shareholders. What do you think about this?

6
Dec 05, 2011 06:33PM
11
Dec 05, 2011 07:57PM
7
Dec 05, 2011 08:06PM
7
Dec 05, 2011 10:23PM
Share
New Message
Please login to post a reply